Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Added Value of Early Collected Ultrasound As Compared to Clinical Evaluation to Predict Definite Clinical Outcome and Therapeutic Response in Rheumatoid Arthritis Patients Treated by JAK Inhibitors

NCT04084223 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04084223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04084223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Added Value of Early Collected Ultrasound As Compared to Clinical Evaluation to Predict Definite Clinical Outcome and Therapeutic Response in Rheumatoid Arthritis Patients Treated by JAK Inhibitors
Lead sponsor
University Hospital, Montpellier
Phase
Not applicable
Overall status
Terminated
Start date
October 10, 2019
Completion date
September 24, 2024
Enrollment
51 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis